Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $89.75 Consensus Price Target from Brokerages
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and one has given a strong buy recommendation to […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and one has given a strong buy recommendation to […]
